We have tested the hypothesis that guaninenucleotide-binding-protein-coupled receptors may be able to interact with each other at a molecular level. 
ance of specific binding sites (30-35 fmol/mg of membrane protein) for both radioligands. These sites displayed ligand binding properties similar to those of the two wild-type receptors. Furthermore, COS-7 cells cotransfected with Ca2/m3 and m3/a2 were able to mediate a pronounced stimulation of phosphatidylinositol hydrolysis upon stimulation with the muscarinic agonist carbachol (E..ax 40-50% of wild-type m3). A mutant m3 receptor (containing 16 amino acids of m2 receptor sequence at the N terminus of the third cytoplasmic loop) that was capable of binding muscarinic ligands but was virtually unable to stimulate phosphatidylinositol hydrolysis was also used in various cotransfection experiments. Coexpression of this chimeric receptor with other functionally impaired mutant muscarinic receptors (e.g., with an m3 receptor containing a Pro -* Ala point mutation in transmembrane region VII) resulted in a considerable stimulation of phosphatidylinositol breakdown after carbachol treatment (E..
-40-50% of wild-type m3). Thus, these data suggest that guaninenucleotide-binding-protein-coupled receptors can interact with each other at a molecular level. One may speculate that the formation of receptor dimers involving the intermolecular exchange of N-and C-terminal receptor domains (containing transmembrane domains I-V and VI and VII, respectively) may underlie this phenomenon.
Muscarinic acetylcholine receptors (ml-m5) are integral membrane proteins that, upon agonist stimulation, interact with guanine nucleotide binding proteins (G proteins) to induce a variety of intracellular responses (1, 2) . Like all other G-protein-coupled receptors, the muscarinic receptors are predicted to be composed of seven hydrophobic transmembrane domains (TMD I-VII), connected by alternating intra-and extracellular loops. Whereas several of the transmembrane regions have been shown to be involved in ligand binding (2) (3) (4) , the specificity of G-protein coupling is primarily determined by the membrane-proximal portions of the third cytoplasmic loop (i3; refs. 5-8).
We have shown (9) that muscarinic receptors behave structurally in a fashion analogous to two-subunit receptors. When truncated m2 or m3 receptors (containing TMD I-V) were coexpressed in COS-7 cells with gene fragments coding for the corresponding C-terminal receptor portions (containing TMD VI and VII), functional muscarinic receptors with ligand binding properties similar to those of the two wild-type receptors were obtained. Similar findings have also been described for "split" /32-adrenergic receptors coexpressed in Xenopus oocytes (10) . Based on these results, we have speculated that the association of N-(containing TMD I-V) and C-terminal receptor domains (containing TMD VI and VII) may occur not only intra-but also intermolecularly, thus providing a molecular basis for receptor dimerization.
To test the hypothesis that G-protein-coupled receptors are in fact able to interact with each other at a molecular level, we initially created two chimeric receptor molecules, a2/m3 and m3/a2 (Fig. 1) , in which the C-terminal receptor domains (including TMD VI and VII) were exchanged between the a2C-adrenergic (in the following referred to as a2) and the m3 muscarinic receptor. The two mutant receptors were expressed in COS-7 cells, either alone or in combination, and studied for their ability to bind muscarinic and adrenergic ligands and to stimulate phosphatidylinositol (PI) hydrolysis. Furthermore, coexpression studies were performed with various mutant m3 muscarinic receptors that functionally were severely impaired or completely inactive (Fig. 1) . The results of these studies suggest that muscarinic receptors can functionally interact with each other at the protein level.
MATERIALS AND METHODS
Preparation of Mutant Receptor Constructs. Rm3pcD (12) and Ra2pRc/CMV (ref. 13 ; kindly provided by H. Chin, National Institutes of Health, Bethesda, MD), two mammalian expression vectors containing the entire coding sequence of the rat m3 muscarinic and the rat a2c-adrenergic receptor, respectively, were used to construct a2/m3 and m3/a2 (Fig.  1) . Expression plasmids coding for these two chimeric receptors (pcDa2/m3 and pcDm3/a2) were created as follows.
pcDa2/m3. A 0.67-kb Hinfl-Acc I fragment (containing the coding sequence for TMD I-V of the a2-adrenergic receptor) was removed from Ra2pRc/CMV and ligated, via a synthetic DNA linker sequence (encoding the last amino acid of TMD V of the a2-adrenergic receptor and the first 10 amino acids of the i3 loop of the m3 muscarinic receptor), with the 5.7-kb PpuMI-BstXI restriction fragment from Rm3pcD. The resulting construct encoded a chimeric receptor (a2/m3) conAbbreviations: G protein, guanine nucleotide binding protein; 4-DAMP, 4-diphenylacetoxy-N-methylpiperidine methiodide; i3, the third cytoplasmic loop of G-protein-coupled receptors; PI, phosphatidylinositol; IP1, inositol monophosphate; NMS, N-methylscopolamine; TMD, transmembrane domain ofG-protein-coupled receptors. *To whom reprint requests should be addressed.
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sisting of the first 187 amino acids of the a2-adrenergic receptor and the last 338 amino acids of the m3 muscarinic receptor ( Fig. 1 ). pcDm3/a2. An Nhe I site was created at the C terminus of the i3 loop in Rm3pcD by a PCR procedure, leaving unchanged the amino acid sequence of the i3 loop. A 0.95-kb Dra III-Nhe I restriction fragment was removed from this construct and replaced with a 0.23-kb PCR fragment encoding the C-terminal domains of the a2-adrenergic receptor (including TMD VI and VII). The encoded chimeric receptor (m3/a2) consisted of the first 491 amino acids of the m3 muscarinic receptor and the last 75 amino acids of the a2-adrenergic receptor (Fig. 1) .
pcDm3-trunc. A 0.70-kb BstXI-Nhe I restriction fragment was removed from Rm3pcD and replaced with a synthetic linker containing an in-frame stop codon after amino acid codon 272 of the rat m3 receptor sequence (Fig. 1) . The encoded truncated receptor (m3-trunc) contained only the first 21 amino acids of the i3 loop.
pcDm2-trunc. A 5.3-kb Sst I restriction fragment was removed from Hm2pcD (an expression plasmid coding for the human m2 muscarinic receptor, see ref. 12 ) and subjected to self-ligation, resulting in the creation of a stop codon after amino acid codon 283 (located in the middle of the i3 loop) of the m2 receptor sequence.
The construction of expression plasmids coding for m3/ m2(16aa) (a receptor in which the first 16 amino acids of the i3 loop of the rat m3 receptor have been replaced with the corresponding segment of the human m2 receptor) and m3(P540-+A) (an m3 receptor in which Pro-540 was replaced with Ala) has been described (5, 11) . The identity of all mutations and the correctness of all PCR-derived coding sequences were confirmed by dideoxynucleotide sequencing of the mutant plasmids (14) . Carbachol-induced increases in intracellular inositol monophosphate (IP1) levels were determined as described (17 with wild-type affinities (5, 6) but is virtually unable to mediate stimulation of PI hydrolysis (refs. 5 and 6; Fig. 3B ). m3-Trunc (Fig. 1) represents a truncated m3 receptor that was unable to bind muscarinic ligands or to mediate a functional response (Fig. 3B and Table 2 ). However, when m3/m2(16aa) and m3-trunc were coexpressed in COS-7 cells, a considerable increase in intracellular IP1 levels (84 ± 15% above basal) was observed after carbachol stimulation.
In another set of experiments, m3/m2(16aa) was coexpressed with a mutant m3 receptor (m3[P540-*A]; Fig. 1 ) containing a point mutation in TMD VII. m3(P540-+A) has been shown to bind muscarinic agonists and antagonists with high affinity but is functionally severely impaired (ref. Fig. 3C ). Interestingly, m3/m2(16aa) and m3(P540-*A) were able to induce a significant stimulation of PI breakdown (89 + 4%) when the two mutant receptors were coexpressed in COS-7 cells (Fig. 3C and Various observations, in addition to the significant number of detectable receptor sites, argue against the possibility that homologous recombination events (resulting in the creation of wild-type plasmid DNA), rather than intermolecular interactions at the protein level, are responsible for the appearance of functional receptors after coexpression of a2/m3 and m3/a2. (i) Coexpression of a truncated m2 receptor, m2-trunc (containing TMD I-V and the N-terminal half of the i3 loop), with a2/m3 resulted in a considerable number of
[3H]NMS binding sites ('50 fmol/mg of protein), whereas none of the two mutant proteins was able to bind muscarinic ligands when expressed alone. Since m2-trunc shares virtually no sequence homology with the m3 receptor sequence present in a2/m3 (18) , protein-protein interactions, rather than homologous recombination events, appear to be responsible for this phenomenon. (ii) The muscarinic binding sites detected after cotransfection of COS-7 cells with a2/m3 and m3/a2 showed an -5-fold lower affinity for acetylcholine than the wild-type receptor, thus clearly arguing against the "accidental" creation of wild-type m3 receptor due to homologous recombination events.
Coexpression experiments involving fragmented muscarinic (9) or adrenergic (10) receptors provide a possible clue as to the molecular basis underlying the functional interaction between a2/m3 and m3/a2. These studies have shown that muscarinic and 82-adrenergic receptors behave in a fashion analogous to two-subunit receptors (Fig. 4) . For example, coexpression in COS-7 cells of a truncated m3 receptor (containing TMD I-V) with the corresponding C-terminal receptor fragment (containing TMD VI and VII) resulted in the "reconstitution" of functional muscarinic receptors that were able to stimulate PI hydrolysis to a maximum extent similar to that of the wild-type receptor (9) . One may therefore speculate that, in the coexpression experiments described above, the C-terminal portion of a2/m3 is able to interact with the N-terminal portion of m3/a2 to create FIG. 4. Model depicting the hypothetical subunit character of muscarinic receptors based on coexpression studies with fragmented m2 and m3 receptors (9) . The seven cylinders represent TMD I-VII, whereas the solid circles mark extramembranous receptor sequences. The third cytoplasmic loop (i3) is thought to act as a linker sequence between two structural receptor subunits (one containing TMD I-V and the other containing TMD VI and VII). functional muscarinic receptors. An analogous mechanism may explain the appearance of a2-adrenergic binding sites observed after coexpression of a2/m3 and m3/a2.
Further evidence supporting the concept of intermolecular cross-talk between G-protein-coupled receptors was derived from cotransfection experiments involving the use of two additional mutant m3 muscarinic receptors, m3/m2(16aa) and m3(P540-)A) (for structures, see Fig. 1 ). In contrast to a2/m3 and m3/a2, these two mutant receptors, when expressed alone, were able to bind muscarinic agonists and antagonists with high affinity (5, 6, 11) . However, both mutant proteins were found to be severely impaired in their ability to activate PI metabolism (5, 6, 11) . Coexpression of m3/m2(16aa) and m3(P540->A) in COS-7 cells, followed by carbachol stimulation, resulted in a significant stimulation of PI hydrolysis (E,: 40-50% of wild-type m3). This finding further supports the concept that muscarinic receptors are able to interact with each other at the receptor level, possibly in a fashion analogous to that described above for the interaction between a2/m3 and m3/a2.
Consistent with this proposal, photoaffinity labeling studies (followed by gel electrophoresis) have shown that rat heart and brain muscarinic receptors can exist in dimeric forms (19, 20) . A similar conclusion has been reached based on a systematic analysis of the agonist binding properties of muscarinic receptors in various rat tissues (21, 22) . Interestingly, it has been proposed that serotonin 5-HT2 and 5-HTlA receptors, based on the presence ofleucine-zipper sequences in individual transmembrane segments, may also be capable of dimer formation (23) .
In conclusion, we have demonstrated that muscarinic receptors are able to functionally interact with each other at a molecular level. Moreover, we have proposed a model in which receptor dimerization is dependent on the intermolecular exchange of N-and C-terminal receptor domains (containing TMD I-V and VI and VII, respectively). Based on the high structural homology found among all G-protein-coupled receptors, our findings should be of general importance for the entire receptor superfamily.
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